Female chief executives remain exceedingly rare in the drug industry, accounting for less than 10% of biotech’s top leaders ? a “shockingly, ridiculously low” number, said one of the few women heading a biotech, Veracyte’s Bonnie Anderson.
Source: Number of female biotech CEOs remains ‘shockingly low,’ putting spotlight on BIO | BioPharma Dive
